Skip to content

Influence of support on intra-abdominal pressure, hepatic kinetics of indocyanine green and extravascular lung water during Prone Positioning (PP) in ARDS patients: a randomised crossover study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67999735
Enrollment
20
Registered
2005-04-26
Start date
2003-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome (ARDS) Respiratory Respiratory disorders

Interventions

Baseline measurements were performed in the supine position after one hour of steady-state conventional mechanical ventilation. Then the following two periods of PP were randomised: 1. 6 hours of PP

Sponsors

Sainte Marguerite Hospital (France)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Twenty consecutive patients with ARDS were included and turned prone in the medical intensive care unit of Sainte Marguerite University Hospital in Marseille, France. Patients were prospectively included in this study after obtaining written informed consent from the next of kin. The study design was approved by the Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale of Marseille. ARDS was defined in accordance with the recommendations of the American/European Consensus Conference.

Exclusion criteria

Exclusion criteria: Patients with unstable cardiovascular function, cerebral injury or unstable spinal fractures, patients subjected to major abdominal surgery and patients with a history of neuromuscular disease were excluded.

Design outcomes

Primary

MeasureTime frame
1. Intra-Abdominal Pressure (IAP) 2. Plasma Disappearance Rate of Indocyanine Green (PDRICG) 3. Extravascular Lung Water (EVLW) 4. Partial Pressure of Oxygen in Arterial Blood (PaO2)/Fraction of Inspired Oxygen (FiO2) ratio 5. Central Venous Pressure (CVP) 6. Mean pulmonary arterial pressure 7. Pulmonary artery occlusion pressure

Secondary

MeasureTime frame
No secondary outcome measures

Countries

France

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026